miR-9靶向FOXP1对弥漫性大B细胞淋巴瘤细胞的作用及机制研究(5)
[19]Dekker JD，Park D，Shaffer AL，et al.Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1[J].Proc Natl Acad Sci USA，2016，113(5)：E577-E586.
[20]van Keimpema M，Grüneberg LJ，Schilder-Tol EJ，et al.The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells[J].Haematologica，2017，102(3)：573-583.
[21]van Keimpema M，Grüneberg LJ，Mokry M，et al.FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-kappaB to promote survival of human B cells[J].Blood，2014，124(23)：3431-3440.
[22]Brown PJ，Wong KK，Felce SL，et al.FOXP1 suppresses immune response signatures and MHC class Ⅱ expression in activated B-cell-like diffuse large B-cell lymphomas[J].Leukemia，2016，30(3)：605-616.
[23]Visco C，Li Y，Xu-Monette ZY，et al.Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma：a report from the International DLBCL Rituximab-CHOP Consortium Program Study[J].Leukemia，2012，26(9)：2103-2113.
(收稿日期：2019-07-04 本文編辑：孟庆卿), 百拇医药(闻淑娟 张珍连 李姗 胡欣 朱琳 阿孜古丽·麦合麦提 杨顺娥)
[20]van Keimpema M，Grüneberg LJ，Schilder-Tol EJ，et al.The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells[J].Haematologica，2017，102(3)：573-583.
[21]van Keimpema M，Grüneberg LJ，Mokry M，et al.FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-kappaB to promote survival of human B cells[J].Blood，2014，124(23)：3431-3440.
[22]Brown PJ，Wong KK，Felce SL，et al.FOXP1 suppresses immune response signatures and MHC class Ⅱ expression in activated B-cell-like diffuse large B-cell lymphomas[J].Leukemia，2016，30(3)：605-616.
[23]Visco C，Li Y，Xu-Monette ZY，et al.Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma：a report from the International DLBCL Rituximab-CHOP Consortium Program Study[J].Leukemia，2012，26(9)：2103-2113.
(收稿日期：2019-07-04 本文編辑：孟庆卿), 百拇医药(闻淑娟 张珍连 李姗 胡欣 朱琳 阿孜古丽·麦合麦提 杨顺娥)